biotech

biotech

First gene therapy for rare subtype of Charcot-Marie-Tooth disease clears hurdle

biotech

Positive results from Crohn’s disease trial

biotech

Crystalys Therapeutics launches with $205m to take on gout

biotech

New radiopharmaceutical preclinical CRO created

biotech

JV to develop small molecule targeting DNA damage response in glioblastoma

biotech

Tumour cells exploit damaged tissue in the pancreas

biotech

Imlifidase successfully meets primary kidney transplantation endpoint

biotech

Base to Base biotech podcast 29: Blood pressure and radiopharmaceuticals